{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:16Z","timestamp":1792788496542,"version":"4.5.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IWT","award":["120829"],"award-info":[{"award-number":["120829"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164080","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T13:51:17Z","timestamp":1475761877000},"page":"e0164080","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":161,"title":["JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases"],"prefix":"10.1371","volume":"11","author":[{"given":"Ana Karina","family":"Alves de Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhart","family":"Speeckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Desmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Van Gele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"De Schepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2008.03.002","article-title":"Cytokine Signaling Modules in Inflammatory Responses","volume":"28","author":"JJ O\u2019Shea","year":"2008","journal-title":"Immunity"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/bc.2010.029","article-title":"Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase funcion","volume":"391","author":"A Wohlmann","year":"2010","journal-title":"Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT Signaling in immunity and disease","volume":"194","author":"A V Villarino","year":"2015","journal-title":"J Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention","volume":"66","author":"JJ O\u2019Shea","year":"2015","journal-title":"Annu Rev Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/ced.12273","article-title":"An insight into JAK-STAT signalling in dermatology","volume":"39","author":"J a. Palanivel","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.det.2014.09.006","article-title":"An update on topical therapies for mild-moderate psoriasis","volume":"33","author":"KPC van de","year":"2015","journal-title":"Dermatol Clin"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(14)62113-9","article-title":"Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: A phase 3 randomised non-inferiority trial","volume":"386","author":"H Bachelez","year":"2015","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjd.12266","article-title":"A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis","volume":"169","author":"WC Ports","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaad.2011.12.018","article-title":"Preliminary clinical activity of a topical JAK1\/2 inhibitor in the treatment of psoriasis","volume":"67","author":"N Punwani","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/jid.2011.369","article-title":"An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of MicroRNA-155","volume":"132","author":"A Terlou","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref11","first-page":"1357","article-title":"Possible role of interleukin-17 in the pathogenesis of lichen planus","volume":"166","author":"O Shaker","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1684\/ejd.2012.1725","article-title":"Cytokine and chemokine ligand expression in cutaneous lupus erythematosus","volume":"22","author":"T Gambichler","year":"2012","journal-title":"Eur J Dermatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2249.2004.02649.x","article-title":"Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model","volume":"138","author":"L Chen","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jaci.2011.01.054","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis\u2014Part II: Immune cell subsets and therapeutic concepts","volume":"127","author":"E Guttman-Yassky","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis\u2014Part I: Clinical and pathologic concepts","volume":"127","author":"E Guttman-Yassky","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"L Xing","year":"2014","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/bbrc.1999.1156","article-title":"Evidence for the involvement of JAK\/STAT pathway in the signaling mechanism of interleukin-17","volume":"262","author":"S V Subramaniam","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2741\/4054","article-title":"IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?","volume":"17","author":"A Camporeale","year":"2012","journal-title":"Front Biosci (Landmark Ed"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.archoralbio.2013.04.004","article-title":"Oral lichen planus: focus on etiopathogenesis","volume":"58","author":"MR Payeras","year":"2013","journal-title":"Arch Oral Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e24137","DOI":"10.4161\/jkst.24137","article-title":"The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis","volume":"2","author":"L Bao","year":"2013","journal-title":"Jak-Stat"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00403-013-1379-9","article-title":"Identifying targets for topical RNAi therapeutics in psoriasis: Assessment of a new in vitro psoriasis model","volume":"305","author":"S Bracke","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/gb-2007-8-2-r19","article-title":"qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data","volume":"8","author":"J Hellemans","year":"2007","journal-title":"Genome Biol"},{"key":"ref23","first-page":"819","article-title":"Europe PMC Funders Group JAK2 phosphorylates histone H3Y41 and excludes HP1 \u03b1 from chromatin","volume":"461","author":"M a Dawson","year":"2013","journal-title":"Europe PMC Funders Group JAK2 phosphorylates histone H3Y41 and excludes HP1 \u03b1 from chromatin"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08977194.2011.614949","article-title":"JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth","volume":"29","author":"F Zouein","year":"2011","journal-title":"Growth Factors"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"S Sano","year":"2005","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/exd.12128","article-title":"Studies of Jak\/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity","volume":"22","author":"RM Andr\u00e9s","year":"2013","journal-title":"Exp Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor","volume":"131","author":"K Miyoshi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/1940-6207.CAPR-09-0105","article-title":"STAT2 contributes to promotion of colorectal and skin carcinogenesis","volume":"3","author":"AM Gamero","year":"2010","journal-title":"Cancer Prev Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/jid.2011.222","article-title":"IL-17A Upregulates Keratin 17 Expression in Keratinocytes through STAT1- and STAT3-Dependent Mechanisms","volume":"131","author":"X Shi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.intimp.2015.12.035","article-title":"Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via Jak3\/Stat3 signaling pathway","volume":"32","author":"TT Di","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4049\/jimmunol.0804063","article-title":"JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL\/J mice","volume":"183","author":"BY Chang","year":"2009","journal-title":"J Immunol"},{"key":"ref32","first-page":"1","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","author":"L Xing","year":"2014","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/jid.2014.260","article-title":"Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis","volume":"134","author":"B Craiglow","year":"2014","journal-title":"J Invest Dermatol"},{"key":"ref34","first-page":"109155","article-title":"Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus","volume":"36","author":"J Li","year":"2011","journal-title":"J Cent South Univ"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2015.06.045","article-title":"Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate","volume":"73","author":"LL Levy","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000347184","article-title":"Effects of the Janus kinase inhibitor CP-690550 (tofacitinib) in a rat model of oxazolone-induced chronic dermatitis","volume":"91","author":"Y Fujii","year":"2013","journal-title":"Pharmacology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molimm.2011.12.008","article-title":"IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2\/Stat6 signal transduction pathway: Implication for atopic dermatitis","volume":"50","author":"L Bao","year":"2012","journal-title":"Mol Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-5793(99)01680-4","article-title":"Binding of IL-4 to the IL-13R\u03b11\/IL-4R\u03b1 receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation","volume":"464","author":"S Wery-Zennaro","year":"1999","journal-title":"FEBS Lett"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/exd.12265","article-title":"JAKpot! New small molecules in autoimmune and inflammatory diseases","volume":"23","author":"K Ghoreschi","year":"2014","journal-title":"Exp Dermatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/intimm\/dxt062","article-title":"Tyk2 is a therapeutic target for psoriasis-like skin inflammation","volume":"26","author":"M Ishizaki","year":"2014","journal-title":"Int Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:01:11Z","timestamp":1601110871000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164080"}},"subtitle":[],"editor":[{"given":"Johnson","family":"Rajasingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164080","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]}}}